Citigroup’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$23.2M Sell
1,046,488
-24,759
-2% -$550K 0.01% 672
2025
Q1
$19.9M Buy
1,071,247
+1,017,470
+1,892% +$18.9M 0.01% 709
2024
Q4
$712K Buy
53,777
+38,376
+249% +$508K ﹤0.01% 2796
2024
Q3
$516K Buy
15,401
+4,838
+46% +$162K ﹤0.01% 2967
2024
Q2
$265K Sell
10,563
-68,480
-87% -$1.72M ﹤0.01% 3036
2024
Q1
$1.78M Buy
79,043
+75,423
+2,084% +$1.7M ﹤0.01% 1914
2023
Q4
$77.5K Sell
3,620
-31,508
-90% -$675K ﹤0.01% 3567
2023
Q3
$631K Buy
35,128
+1,334
+4% +$24K ﹤0.01% 2246
2023
Q2
$687K Sell
33,794
-30,928
-48% -$629K ﹤0.01% 2513
2023
Q1
$1.41M Buy
64,722
+30,477
+89% +$663K ﹤0.01% 1772
2022
Q4
$1.06M Sell
34,245
-36,877
-52% -$1.14M ﹤0.01% 1974
2022
Q3
$1.81M Buy
71,122
+29,779
+72% +$760K ﹤0.01% 1666
2022
Q2
$839K Buy
41,343
+31,746
+331% +$644K ﹤0.01% 2207
2022
Q1
$237K Sell
9,597
-28,427
-75% -$702K ﹤0.01% 3313
2021
Q4
$1.32M Buy
38,024
+15,474
+69% +$538K ﹤0.01% 2286
2021
Q3
$612K Sell
22,550
-54,028
-71% -$1.47M ﹤0.01% 2763
2021
Q2
$1.99M Sell
76,578
-37,574
-33% -$974K ﹤0.01% 2109
2021
Q1
$2.46M Buy
114,152
+107,066
+1,511% +$2.31M ﹤0.01% 1820
2020
Q4
$152K Buy
7,086
+3,881
+121% +$83.3K ﹤0.01% 3401
2020
Q3
$47K Sell
3,205
-26,459
-89% -$388K ﹤0.01% 3515
2020
Q2
$662K Sell
29,664
-11,918
-29% -$266K ﹤0.01% 2377
2020
Q1
$587K Sell
41,582
-9,450
-19% -$133K ﹤0.01% 2181
2019
Q4
$829K Buy
51,032
+16,415
+47% +$267K ﹤0.01% 2322
2019
Q3
$1.21M Buy
34,617
+4,524
+15% +$158K ﹤0.01% 1977
2019
Q2
$1.7M Buy
30,093
+28,841
+2,304% +$1.63M ﹤0.01% 1767
2019
Q1
$91K Sell
1,252
-112,080
-99% -$8.15M ﹤0.01% 3643
2018
Q4
$7.23M Buy
113,332
+71,150
+169% +$4.54M 0.01% 836
2018
Q3
$4.21M Sell
42,182
-8,941
-17% -$892K ﹤0.01% 1088
2018
Q2
$3.63M Sell
51,123
-37,382
-42% -$2.66M ﹤0.01% 1170
2018
Q1
$9.21M Sell
88,505
-45,013
-34% -$4.69M 0.01% 737
2017
Q4
$13.4M Buy
133,518
+10,879
+9% +$1.1M 0.01% 563
2017
Q3
$4.29M Buy
122,639
+120,787
+6,522% +$4.22M ﹤0.01% 1045
2017
Q2
$44K Buy
1,852
+1,712
+1,223% +$40.7K ﹤0.01% 3643
2017
Q1
$4K Buy
+140
New +$4K ﹤0.01% 4506